Modern management of malignant pleural mesothelioma
Shivani C Patel,1 Jonathan E Dowell1,2 1Division of Hematology and Oncology, University of Texas Southwestern, 2Section of Hematology and Oncology, Veterans Affairs North Texas Healthcare System, Dallas, TX, USA Abstract: Malignant pleural mesothelioma (MPM) is a deadly disease that produces a sign...
Guardado en:
Autores principales: | Patel SC, Dowell JE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a420535fb0ac49c59fade232196eaa9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
por: Jamil MO, et al.
Publicado: (2017) -
Pain management in patients with malignant mesothelioma: challenges and solutions
por: Saunders J, et al.
Publicado: (2019) -
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
por: Francesca Cersosimo, et al.
Publicado: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
por: Bonomi M, et al.
Publicado: (2017) -
Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial Observations
por: Sebastian Curcean, M.B.B.S., et al.
Publicado: (2021)